MEDERION (formerly PalaMed) supports digital health and medical device companies throughout product development, and engages in communication with regulators to develop, register and launch innovative products in US, European, Australian, and Southeast Asian markets. MEDERION also develops its own portfolio of technologies. MEDERION BRAIN 🧠 is a spin-off of MEDERION. MEDERION BRAIN calculates brain volume in pediatric patient to allow assessment and monitoring of brain tumor and multiple sclerosis. MEDERION BRAIN provides a patient report with total brain volume, hippocampal volume, volumetric data on segments of the brain, and brain tumor volume. MEDERION BRAIN also compares volumes to prior results for monitoring and evolution of brain condition.